These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2910490

  • 1. Androgen dependency of a tumor produced by a cell line derived from androgen-responsive Shionogi carcinoma 115.
    Terada N, Yamamoto R, Uchida N, Takada T, Taniguchi H, Takatsuka D, Sawada M, Tsuji M, Li W, Kitamura Y.
    Cancer Res; 1989 Feb 01; 49(3):693-8. PubMed ID: 2910490
    [Abstract] [Full Text] [Related]

  • 2. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.
    Noguchi S, Nishizawa Y, Nakamura N, Uchida N, Yamaguchi K, Sato B, Kitamura Y, Matsumoto K.
    Cancer Res; 1987 Jan 01; 47(1):263-8. PubMed ID: 3791211
    [Abstract] [Full Text] [Related]

  • 3. Growth-stimulating effect of pharmacological doses of glucocorticoid on androgen-responsive Shionogi carcinoma 115 in vivo in mice and in cell culture.
    Omukai Y, Nakamura N, Hiraoka D, Nishizawa Y, Uchida N, Noguchi S, Sato B, Matsumoto K.
    Cancer Res; 1987 Aug 15; 47(16):4329-34. PubMed ID: 3607765
    [Abstract] [Full Text] [Related]

  • 4. Stimulative effect of physiological doses of androgen or pharmacological doses of estrogen on growth of Shionogi carcinoma 115 in mice.
    Noguchi S, Nishizawa Y, Uchida N, Yamaguchi K, Sato B, Kitamura Y, Matsumoto K.
    Cancer Res; 1985 Nov 15; 45(11 Pt 2):5746-50. PubMed ID: 4053046
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of estrogen enhancement in the growth of androgen-dependent Shionogi carcinoma 115.
    Noguchi S, Takatsuka D, Kitamura Y, Terada N, Uchida N, Yamaguchi K, Sato B, Matsumoto K.
    Cancer Res; 1985 Oct 15; 45(10):4785-90. PubMed ID: 4027967
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory and stimulatory effects of glucocorticoid on androgen-induced growth of murine Shionogi carcinoma 115 in vivo and in cell culture.
    Hiraoka D, Nakamura N, Nishizawa Y, Uchida N, Noguchi S, Matsumoto K, Sato B.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6560-4. PubMed ID: 3677094
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Growth-stimulative effect of estrogen on androgen-dependent Shionogi carcinoma 115.
    Noguchi S, Kitamura Y, Uchida N, Yamaguchi K, Sato B, Matsumoto K.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5644-9. PubMed ID: 6498825
    [Abstract] [Full Text] [Related]

  • 10. Variability of androgen-related phenotypes in the Shionogi mammary carcinoma during growth, involution, recurrence, and progression to hormonal independence.
    Bruchovsky N, Rennie PS, Otal N, Vanson A, Giles M, Pontifex H.
    Cancer Res; 1985 Feb 15; 45(2):682-9. PubMed ID: 3967243
    [Abstract] [Full Text] [Related]

  • 11. Effect of serial passage in female nude athymic mice on androgen dependency of Shionogi carcinoma 115.
    Kitamura Y, Uchida N, Hayata I, Yamaguchi K, Okamoto S, Narita N, Matsumoto K.
    Cancer Res; 1980 Dec 15; 40(12):4781-5. PubMed ID: 7438110
    [Abstract] [Full Text] [Related]

  • 12. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy.
    Emerman JT, Siemiatkowski J.
    Cancer Res; 1984 Apr 15; 44(4):1327-32. PubMed ID: 6704951
    [Abstract] [Full Text] [Related]

  • 13. Maintenance of androgen-, glucocorticoid- or estrogen-responsive growth in shionogi carcinoma 115 subline sustained in castrated mice with high dose of estrogen for 30 generations (3 years).
    Fujita MQ, Yasui T, Sato B, Uchida N, Uchida K, Shiratori O, Takeda K, Matsumoto K.
    Jpn J Cancer Res; 1992 Sep 15; 83(9):995-1001. PubMed ID: 1429212
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhancement by androgen of the angiogenic ability of androgen-responsive Shionogi carcinoma 115.
    Takatsuka D, Uchida N, Yamamoto R, Tsuji M, Terada N, Matsumoto K.
    Anticancer Res; 1992 Sep 15; 12(6B):2001-4. PubMed ID: 1284197
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Action mechanisms of physiological doses of androgen or pharmacological doses of estrogen in growth stimulation of Shionogi carcinoma 115 in mice.
    Nakamura N, Nishizawa Y, Noguchi S, Uchida N, Sato B, Matsumoto K.
    J Steroid Biochem; 1987 Sep 15; 27(1-3):459-64. PubMed ID: 2961936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.